Transparency Market Research Report Added "Fibrin Glue Market" to its database.
Albany, NY -- (SBWIRE) -- 02/18/2016 -- A report from Transparency Market Research, titled 'Fibrin Glue Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023,' states that the global fibrin glue market is expected to expand at a rapid pace during the period from 2016 to 2023 owing to the growing applications of fibrin glue.
Over the past few years, the skills and techniques of surgeries have progressed tremendously. Earlier, suture-like threads made from a variety of substances were used for mechanical closure of wounds. Now, with various hemostats and surgical adhesives, surgical procedures have changed. Surgical adhesives and hemostats include five elements or families, namely fibrin glue, polyethylene glycol polymer, cyanoacrylate, albumin linked with glutaraldehyde, and bovine collagen. Over the past 30 years, fibrin glue has been commonly used in numerous indications throughout various surgical fields.
Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8452
Fibrin glue, a derivative of human blood products and animals, is commonly withdrawn from plasma. Fibrin glue consists of differing quantities of virally inactivated and purified human proteins. Biological fibrin glue contains human fibrinogen and human thrombin. Some of the attractive features of fibrin glue are high internal bond strength, the capacity to improve regeneration of tissue, clot formation, and high surface adherence. Globally, fibrin glue is primarily used in hemostasis, but it can also be used to heal various wounds and also as a biological sealant.
The growing applications of fibrin glue and the many benefits associated with fibrin glue are predicted to propel the global fibrin glue market during the period between 2016 and 2023. Some of the major reasons for the increasing use of fibrin glue are it helps reduce the threat of infection, improves cosmesis, and offers quick hemostasis on all treated parts. By using fibrin glue, surgeons can execute the operations by using minor incisions. Fibrin glue encourages natural healing of the tissues. However, one of the major risk factors associated with fibrin glue is the risk of passing on the infectious organisms from the human body to the glue.
Lately, fibrin glue received approvals from the European Union and the U.S. FDA for its use in cardiovascular surgery and spleen trauma. Some of the commercially prepared sealants from fibrin glue are biocol, beriplast, and tisseel. The global fibrin glue market is segmented on the basis of geography and application. Orthopedic surgeries, neurosurgery, burn bleeding, lacerations of spleen and liver, plastic surgery, cardiac surgery, wound management, general surgery, and pulmonary surgery are some of the applications of the fibrin glue. Currently, the burn bleeding segment and the cardiac surgeries segment are contributing massively to the global fibrin glue market.
Based on geography, the global fibrin glue market is divided into Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. At present, the global fibrin glue market is led by North America due to the growing aging population and the increasing number of surgical procedures in the region. Haemcure Corporation, Omrix Biopharmaceutical, Inc., CSL Behring, Interpore Cross, Baxter International Inc., Vivostat A/S, and Cryolife Inc. are some of the prominent players in the global fibrin glue market.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453